Business Description
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
ISIN : CNE000000BF3
Share Class Description:
SHSE:600671: Class ATotal Employee Number:
392Compare
Compare
Traded in other countries / regions
600671.China Index Membership
SSE Composite Index IPO Date
1993-08-23Description
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.23 | |||||
Equity-to-Asset | 0.16 | |||||
Debt-to-Equity | 2.7 | |||||
Debt-to-EBITDA | 10.46 | |||||
Interest Coverage | 2.58 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 3.56 | |||||
Beneish M-Score | -2.16 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 24.8 | |||||
3-Year FCF Growth Rate | 5.4 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 78.44 | |||||
9-Day RSI | 70.19 | |||||
14-Day RSI | 63.54 | |||||
3-1 Month Momentum % | -22.46 | |||||
6-1 Month Momentum % | -6.93 | |||||
12-1 Month Momentum % | 19.73 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.84 | |||||
Quick Ratio | 0.7 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 164.68 | |||||
Days Sales Outstanding | 242.05 | |||||
Days Payable | 284.76 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -2.08 |
Profitability Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 51.04 | |||||
Operating Margin % | 9.4 | |||||
Net Margin % | 8.02 | |||||
EBITDA Margin % | 9.33 | |||||
FCF Margin % | -13.77 | |||||
OCF Margin % | 0.99 | |||||
ROE % | 24.73 | |||||
ROA % | 3.76 | |||||
ROIC % | 3.28 | |||||
3-Year ROIIC % | 47.66 | |||||
ROC (Joel Greenblatt) % | 7.29 | |||||
ROCE % | 12.01 | |||||
Years of Profitability over Past 10-Year | 5 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 143.36 | |||||
PE Ratio without NRI | 123.14 | |||||
Price-to-Owner-Earnings | 835.22 | |||||
PS Ratio | 11.48 | |||||
PB Ratio | 31.7 | |||||
Price-to-Tangible-Book | 34.93 | |||||
Price-to-Operating-Cash-Flow | 1130 | |||||
EV-to-EBIT | 132.31 | |||||
EV-to-EBITDA | 132.31 | |||||
EV-to-Revenue | 12.35 | |||||
EV-to-FCF | -89.67 | |||||
Price-to-GF-Value | 1.28 | |||||
Price-to-Median-PS-Value | 1.52 | |||||
Price-to-Graham-Number | 13.82 | |||||
Earnings Yield (Greenblatt) % | 0.76 | |||||
FCF Yield % | -1.2 | |||||
Forward Rate of Return (Yacktman) % | 2.4 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 203.849 | ||
| EPS (TTM) (Â¥) | 0.134 | ||
| Beta | 0.2911 | ||
| 3-Year Sharpe Ratio | 0.71 | ||
| 3-Year Sortino Ratio | 1.58 | ||
| Volatility % | 50.1 | ||
| 14-Day RSI | 63.54 | ||
| 14-Day ATR (Â¥) | 1.014037 | ||
| 20-Day SMA (Â¥) | 17.5745 | ||
| 12-1 Month Momentum % | 19.73 | ||
| 52-Week Range (Â¥) | 13.21 - 23.44 | ||
| Shares Outstanding (Mil) | 121.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| 1.0177:1 Stock Split | 2009-05-04 | 7.59 (+5.90%) | ||
| 1.08:1 Stock Split | 2006-12-15 | 5.21 (+0.00%) | ||
| 1.5:1 Stock Split | 1997-02-24 | 6.03 (+2.69%) | ||
| 1.16:1 Stock Split | 1996-07-19 | 3.00 (-0.52%) | ||
| 1.2:1 Stock Split | 1994-06-06 | 2.96 (-1.31%) |
Show
Entries
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd Frequently Asked Questions
What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671)'s stock price today?
The current price of SHSE:600671 is ¥19.21. The 52 week high of SHSE:600671 is ¥23.44 and 52 week low is ¥13.21.
When is next earnings date of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671)?
The next earnings date of Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671) is .
Does Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671) pay dividends? If so, how much?
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd(SHSE:600671) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers